Illumina MiSeq Silver Plan Preventative Maintenance

The FDA's Office of Acquisition and Grant Services is soliciting quotations for an Illumina MiSeq Silver Plan Preventative Maintenance contract to support an existing Illumina MiSeq sequencing instrument (Serial Number M04120) currently used by the FDA's Office of Laboratory Operations and Applied Science. This procurement seeks comprehensive manufacturer-specified maintenance services and parts under the Silver Plan service agreement for analytical laboratory equipment manufacturing (NAICS 334516). Contractors must submit two-volume proposals including a technical volume limited to 10 pages detailing equipment specifications, work schedule, warranty, and delivery timeline, along with a separate pricing volume. The evaluation will consider both technical compliance and price as approximately equal factors, with the government anticipating selection of the best-suited quoter from initial responses without subsequent negotiations. The question submission deadline is June 24, 2025, at 12:00 PM Eastern Time, with quotations due by June 27, 2025.

This solicitation is designated for unrestricted full and open competition with no set-aside provisions, making it available to all qualified contractors under the small business size standard of 1,000 employees. The contract structure includes a 12-month base period with four optional 12-month extension periods, potentially extending coverage from January 14, 2025, through January 13, 2030, for a total possible duration of five years. While the attached pricing sheet shows placeholder values of $0 for all Contract Line Item Numbers (CLINs), indicating that specific pricing details will be determined during the procurement process, the contract covers five separate line items corresponding to the base year and each optional year. Performance will take place at the FDA facility in Laurel, Maryland, where the sequencing instrument is currently located and operational.